To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the session by navigating to the timestamp indicated below

0:00:00
Oveporexton (TAK-861) Improves Wakefulness in People with NT1: Assessment of At-home Napping and In-clinic Microsleeps
Brian Tracey (United States)

0:13:50
Initial preclinical development of a novel dual orexin receptor agonist
Alessandro Silvani (Italy)

0:27:20
Optogenetic activation of the histaminergic system in the amygdala of narcoleptic mice reduces the occurrence of cataplexy
Christelle Peyron (France)

0:40:40
The Effect of Pitolisant on Sleep-Promoting Neurons
Thomas Scammell (United States)

0:50:00
iSPHYNCS: An Update on the Internationalization and New Approaches of the Swiss Primary HYpersomnolence and Narcolepsy Cohort Study
Markus Schmidt (Switzerland)

1:02:50
E2086, a Selective Orexin Receptor-2 Agonist, Study for Promoting Wakefulness in Patients With Narcolepsy Type-1
Jocelyn Cheng (United States)